aDepartment of Oncology, Shandong Provincial Hospital Affiliated to Shandong First Medical University
bThe Second Clinical Medical College, Shandong University of Traditional Chinese Medicine
cThe Clinical Medical College, Shandong First Medical University (Shandong Academy of Medicine)
dDepartment of Pathology, Shandong Provincial Hospital, Cheeloo College of Medicine
eDepartment of Oncology
fDepartment of Central Laboratory, Shandong Provincial Hospital
gDepartment of Biostatistics, School of Public Health, Cheeloo College of Medicine, Shandong University
hLaboratory Animal Center
iDepartment of Pathology
jTraditional Chinese Medicine, Shandong Provincial Hospital affiliated to Shandong First Medical University, Jinan, China
Received 28 September 2022 Revised form accepted 29 September 2022.
*Dr. Jingjiang Lai and Dr. Xiaoli Zhuo contributed equally to the writing of this article.
Supplemental Digital Content is available for this article. Direct URL citations appear in the printed text and are provided in the HTML and PDF versions of this article on the journal's website, www.anti-cancerdrugs.com.
Correspondence to Dr. Guobin Fu, Department of Oncology, Shandong Provincial Hospital Affiliated to Shandong First Medical University, No. 324, Jingwuweiqi Road, Huaiyin District, Jinan City, Shandong Province, Jinan, China, Tel: +0531 68776357; e-mail:[email protected]